Vitamin B12 injections versus oral supplements. How much money could be saved by switching from injections to pills?
C van Walraven, P Austin, C D Naylor, C van Walraven, P Austin, C D Naylor
Abstract
Objective: To estimate savings, using a third-party payer perspective, if all elderly patients currently receiving vitamin B12 (cobalamin) injections were switched to high-dose oral therapy.
Design: We modeled high-dose oral B12 supplement costs to include drugs, pharmacists' fees, and one-time conversion costs consisting of two physician visits and laboratory monitoring. The number of vitamin-injection visits avoided by switching to oral therapy was predicted using a multivariate model that considered covariates for overall patient illness.
Setting: Ontario family physicians' and internists' practices.
Participants: Population-based administrative databases for Ontario were used to identify all people between 65 and 100 years who received parenteral vitamin B12 during 1995 and 1996.
Main outcome measures: The cost of parenteral vitamin B12 for each patient, including drugs, injections, pharmacists' fees, and injection-associated physician visits, was measured directly from the databases.
Results: The annual cost of parenteral vitamin B12 therapy averaged $145.88 per person and totaled a maximum $25 million over 5 years. Converting all patients to high-dose oral B12 and treating them for 5 years would cost $7.4 million. Depending on how many vitamin-injection visits are avoided by switching to oral therapy, between $2.9 million and $17.6 million would be saved. Switching to oral B12 administration saved costs as long as 16.3% of injection-associated visits were avoided.
Conclusion: Switching all patients from B12 injections to oral cobalamin therapy could result in substantial savings.
References
- Ann Intern Med. 1963 May;58:810-7
- CMAJ. 1999 Mar 23;160(6):805-11
- Acta Med Scand. 1978;204(1-2):81-4
- Am J Med. 1983 May;74(5):765-72
- Br Med J (Clin Res Ed). 1985 Apr 27;290(6477):1254-5
- Br Med J (Clin Res Ed). 1985 Jul 6;291(6487):56
- JAMA. 1991 Jan 2;265(1):94-5
- JAMA. 1991 Jan 2;265(1):96-7
- CMAJ. 1992 Feb 15;146(4):473-81
- J R Soc Med. 1993 May;86(5):308-9
- Mayo Clin Proc. 1994 Feb;69(2):144-50
- Med Care. 1994 Jul;32(7 Suppl):JS52-64
- Wis Med J. 1994 May;93(5):203-5
- Crit Rev Clin Lab Sci. 1996;33(4):247-356
- J Am Geriatr Soc. 1997 Jan;45(1):124-5
- Can Fam Physician. 1997 May;43:917-22
- J Pediatr Hematol Oncol. 1997 May-Jun;19(3):245-6
- Am J Clin Nutr. 1997 Oct;66(4):741-9
- Blood. 1998 Aug 15;92(4):1191-8
- J Am Geriatr Soc. 1998 Sep;46(9):1125-7
- Lancet. 1998 Nov 28;352(9142):1721-2
- Acta Med Scand. 1968 Oct;184(4):247-58
Source: PubMed